Your browser doesn't support javascript.
loading
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach.
Went, M; Sud, A; Law, P J; Johnson, D C; Weinhold, N; Försti, A; van Duin, M; Mitchell, J S; Chen, B; Kuiper, R; Stephens, O W; Bertsch, U; Campo, C; Einsele, H; Gregory, W M; Henrion, M; Hillengass, J; Hoffmann, P; Jackson, G H; Lenive, O; Nickel, J; Nöthen, M M; da Silva Filho, M I; Thomsen, H; Walker, B A; Broyl, A; Davies, F E; Langer, C; Hansson, M; Kaiser, M; Sonneveld, P; Goldschmidt, H; Hemminki, K; Nilsson, B; Morgan, G J; Houlston, R S.
Afiliación
  • Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Sud A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Johnson DC; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Weinhold N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Försti A; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • van Duin M; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Mitchell JS; Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Chen B; Center for Primary Health Care Research, Lund University, Malmo, Sweden.
  • Kuiper R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Stephens OW; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Bertsch U; Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Campo C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Einsele H; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Gregory WM; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Henrion M; National Center for Tumor Diseases, Heidelberg, Germany.
  • Hillengass J; Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Hoffmann P; Department of Internal Medicine II, Division of Hematology and Medical Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Jackson GH; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Lenive O; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Nickel J; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Nöthen MM; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • da Silva Filho MI; Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Thomsen H; Royal Victoria Infirmary, Newcastle upon Tyne, Newcastle, UK.
  • Walker BA; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Broyl A; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Davies FE; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Langer C; Department of Genomics, Life &Brain Center, University of Bonn, Bonn, Germany.
  • Hansson M; Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Kaiser M; Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Sonneveld P; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Goldschmidt H; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hemminki K; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Nilsson B; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Morgan GJ; Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Houlston RS; Hematology Clinic, Skåne University Hospital, Lund, Sweden.
Blood Cancer J ; 7(6): e573, 2017 06 16.
Article en En | MEDLINE | ID: mdl-28622301
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sitios de Carácter Cuantitativo / Estudio de Asociación del Genoma Completo / Análisis de la Aleatorización Mendeliana / Mieloma Múltiple / Obesidad Tipo de estudio: Clinical_trials Idioma: En Revista: Blood Cancer J Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sitios de Carácter Cuantitativo / Estudio de Asociación del Genoma Completo / Análisis de la Aleatorización Mendeliana / Mieloma Múltiple / Obesidad Tipo de estudio: Clinical_trials Idioma: En Revista: Blood Cancer J Año: 2017 Tipo del documento: Article